HengKuan的个人主页 - 老虎社区

HengKuan

HengKuan

暂无个人介绍

IP属地：未知

751关注

105粉丝

0主题

0勋章

2021-12-27

Like

A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State

2021-12-01

Like

Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff

2021-11-25

Like

Global-E Online To Acquire Flow Commerce For ~$500M

2021-11-13

like

@机构有话说:美股的利空是被暂时压制，突然爆发的一天可能不远了

2021-10-06

Like

Wall Street closes sharply higher as Big Tech roars back

2021-03-09

[惊讶]

Apple stock sank more than 2%

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3561674412609852,"uuid":"3561674412609852","gmtCreate":1598582693157,"gmtModify":1612684672568,"name":"HengKuan","pinyin":"hengkuan","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":105,"headSize":751,"tweetSize":191,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"93.03%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":698784280,"gmtCreate":1640559121390,"gmtModify":1640559122516,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698784280","repostId":"1144001147","repostType":4,"repost":{"id":"1144001147","pubTimestamp":1640485026,"share":"https://www.laohu8.com/m/news/1144001147?lang=&edition=full","pubTime":"2021-12-26 10:17","market":"us","language":"en","title":"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State","url":"https://stock-news.laohu8.com/highlight/detail?id=1144001147","media":"InvestorPlace","summary":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, t","content":"<p>In the last year,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.</p>\n<p>However, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with&nbsp;<b>Bharat Biotech</b>. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.</p>\n<p>Beyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.</p>\n<p>Ocugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.</p>\n<p>Let’s talk about the reasons to be bearish.</p>\n<p>FDA Approval Remains Elusive</p>\n<p><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>) and&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.</p>\n<p>Back in June, the biotech company’s&nbsp;application for emergency use authorization&nbsp;was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.</p>\n<p>In November, Ocugen announced that the FDA has “issued a clinical hold&nbsp;on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.</p>\n<p>The key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.</p>\n<p>In July, Ocugen had also initiated a&nbsp;rolling submission to Health Canada&nbsp;for the vaccine. There is no positive news on that front either.</p>\n<p>Let’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.</p>\n<p>Can Omicron Provide a Lifeline for OCGN Stock?</p>\n<p>The omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are&nbsp;currently studying the effectiveness&nbsp;of the vaccine against the variant.</p>\n<p>If the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.</p>\n<p>First and foremost, Moderna has announced that its Covid-19 booster&nbsp;increases neutralizing antibodies 37-fold&nbsp;against Omicron variant.</p>\n<p>Furthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold&nbsp;compared to two doses against the Omicron variant.”</p>\n<p>Clearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.</p>\n<p>People who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.</p>\n<p>It’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.</p>\n<p>OCGN Stock Will Trend Lower</p>\n<p>OCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.</p>\n<p>The company is&nbsp;building a pipeline of drugs&nbsp;for various indications. However, the pipeline for various indications is still at a pre-clinical stage.</p>\n<p>The stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.</p>\n<p>It also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Year After Announcing a Big Partnership, Ocugen Is in a Sorry State\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there...</p>\n\n<a href=\"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144001147","content_text":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.\nHowever, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with Bharat Biotech. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.\nBeyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.\nOcugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.\nLet’s talk about the reasons to be bearish.\nFDA Approval Remains Elusive\nPfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.\nBack in June, the biotech company’s application for emergency use authorization was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.\nIn November, Ocugen announced that the FDA has “issued a clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.\nThe key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.\nIn July, Ocugen had also initiated a rolling submission to Health Canada for the vaccine. There is no positive news on that front either.\nLet’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.\nCan Omicron Provide a Lifeline for OCGN Stock?\nThe omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are currently studying the effectiveness of the vaccine against the variant.\nIf the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.\nFirst and foremost, Moderna has announced that its Covid-19 booster increases neutralizing antibodies 37-fold against Omicron variant.\nFurthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold compared to two doses against the Omicron variant.”\nClearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.\nPeople who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.\nIt’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.\nOCGN Stock Will Trend Lower\nOCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.\nThe company is building a pipeline of drugs for various indications. However, the pipeline for various indications is still at a pre-clinical stage.\nThe stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.\nIt also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609422619,"gmtCreate":1638319233970,"gmtModify":1638319234461,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609422619","repostId":"2188758534","repostType":4,"repost":{"id":"2188758534","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638310020,"share":"https://www.laohu8.com/m/news/2188758534?lang=&edition=full","pubTime":"2021-12-01 06:07","market":"hk","language":"en","title":"Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2188758534","media":"Dow Jones","summary":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\n","content":"<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&amp;P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&amp;P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&amp;P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-01 06:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&amp;P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&amp;P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&amp;P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188758534","content_text":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\nU.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.\nEquities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.\nHow did stock indexes trade?\nThe Dow and S&P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.\nFor the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.\nWhat drove the markets?\nFederal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.\nPowell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.\nPowell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.\nIn One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&P 500 levels in focus\n\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.\n\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.\nPowell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"\nInvestors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.\nStocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna $(MRNA)$ shares fell 4.4%.\nBancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.\n\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.\nAnalysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.\nBancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"\nEchoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.\n\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"\nThe Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.\nEarlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.\n\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874216365,"gmtCreate":1637790855939,"gmtModify":1637790856394,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874216365","repostId":"1147995035","repostType":4,"repost":{"id":"1147995035","pubTimestamp":1637767630,"share":"https://www.laohu8.com/m/news/1147995035?lang=&edition=full","pubTime":"2021-11-24 23:27","market":"us","language":"en","title":"Global-E Online To Acquire Flow Commerce For ~$500M","url":"https://stock-news.laohu8.com/highlight/detail?id=1147995035","media":"Benzinga","summary":"Global-E Online Ltd has agreed to acquire Flow Commerce Inc, a technology-based cross-border e-comme","content":"<p><b>Global-E Online Ltd</b>&nbsp;has&nbsp;agreed to acquire&nbsp;<b>Flow Commerce Inc</b>, a technology-based cross-border e-commerce software solution provider, for about $500 million. Flow Commerce, founded in 2015 by Rob Keve and Mike Bryzek, is based in Hoboken, NJ.</p>\n<ul>\n <li>The purchase price comprises a base consideration of $425 million and up to $75 million in potential additional consideration based on specific financial results in 2021, plus $45 million in Global-E shares for certain assumed, performance-based vesting warrants for Flow Commerce shares.</li>\n <li>The company expects the acquisition to strengthen its offering and capabilities, allowing access to the market of small merchants not currently eligible to use Global-E's services.</li>\n <li>Flow Commerce is expected to generate approximately $20 million in net revenues in the calendar year 2021.</li>\n <li>Global-E expects the deal to close during Q1 2022.</li>\n <li>Global-E Online&nbsp;held $395.8 million in cash and equivalents&nbsp;as of September 30, 2021.</li>\n <li><b>Price Action:</b>&nbsp;GLBE shares are trading higher by 2.75% at $54.12 on the last check Wednesday.</li>\n</ul>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Global-E Online To Acquire Flow Commerce For ~$500M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGlobal-E Online To Acquire Flow Commerce For ~$500M\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-24 23:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/m-a/21/11/24273349/global-e-online-to-acquire-flow-commerce-for-500m><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Global-E Online Ltd has agreed to acquire Flow Commerce Inc, a technology-based cross-border e-commerce software solution provider, for about $500 million. Flow Commerce, founded in 2015 by Rob Keve ...</p>\n\n<a href=\"https://www.benzinga.com/m-a/21/11/24273349/global-e-online-to-acquire-flow-commerce-for-500m\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GLBE":"Global-E Online Ltd."},"source_url":"https://www.benzinga.com/m-a/21/11/24273349/global-e-online-to-acquire-flow-commerce-for-500m","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147995035","content_text":"Global-E Online Ltd has agreed to acquire Flow Commerce Inc, a technology-based cross-border e-commerce software solution provider, for about $500 million. Flow Commerce, founded in 2015 by Rob Keve and Mike Bryzek, is based in Hoboken, NJ.\n\nThe purchase price comprises a base consideration of $425 million and up to $75 million in potential additional consideration based on specific financial results in 2021, plus $45 million in Global-E shares for certain assumed, performance-based vesting warrants for Flow Commerce shares.\nThe company expects the acquisition to strengthen its offering and capabilities, allowing access to the market of small merchants not currently eligible to use Global-E's services.\nFlow Commerce is expected to generate approximately $20 million in net revenues in the calendar year 2021.\nGlobal-E expects the deal to close during Q1 2022.\nGlobal-E Online held $395.8 million in cash and equivalents as of September 30, 2021.\nPrice Action: GLBE shares are trading higher by 2.75% at $54.12 on the last check Wednesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879403155,"gmtCreate":1636759420177,"gmtModify":1636759420669,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879403155","repostId":"879195458","repostType":1,"repost":{"id":879195458,"gmtCreate":1636687707970,"gmtModify":1636733442557,"author":{"id":"126199392658083","authorId":"126199392658083","name":"机构有话说","avatar":"https://static.tigerbbs.com/d8a79f8da6559cae9d644c1c24d24737","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"美股的利空是被暂时压制，突然爆发的一天可能不远了","htmlText":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","listText":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","text":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","images":[{"img":"https://static.tigerbbs.com/493bd241b2cc511739e806ebe4a1f4cb","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879195458","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829374520,"gmtCreate":1633477873122,"gmtModify":1633477874763,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829374520","repostId":"1101968131","repostType":4,"repost":{"id":"1101968131","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633473672,"share":"https://www.laohu8.com/m/news/1101968131?lang=&edition=full","pubTime":"2021-10-06 06:41","market":"us","language":"en","title":"Wall Street closes sharply higher as Big Tech roars back","url":"https://stock-news.laohu8.com/highlight/detail?id=1101968131","media":"Reuters","summary":"Oct 5  - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.Apple, Microsoft, Amazon and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.Facebook Inc rebounded 2.1% a day after taking a beating when its a","content":"<ul>\n <li>Facebook bounces as services resume following outage</li>\n <li>Tech and financials among top advancers</li>\n <li>PepsiCo gains on raising annual revenue forecast</li>\n <li>Indexes: Dow +0.92%, S&amp;P 500 +1.05%, Nasdaq +1.25%</li>\n</ul>\n<p>Oct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.</p>\n<p>Apple, Microsoft, Amazon&nbsp;and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.</p>\n<p>Facebook Inc&nbsp;rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with financials, communication services&nbsp;and technology&nbsp;leading the way.</p>\n<p>The S&amp;P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.</p>\n<p>\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"</p>\n<p>Technology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.</p>\n<p>The Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.</p>\n<p>Investors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.</p>\n<p>Adding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.</p>\n<p>Data from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.92% to end at 34,314.67 points, while the S&amp;P 500&nbsp;gained 1.05% to 4,345.72.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.25% to 14,433.83.</p>\n<p>The S&amp;P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.</p>\n<p>PepsiCo Inc&nbsp;gained 0.6% after raising its full-year revenue forecast.</p>\n<p>Volume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes sharply higher as Big Tech roars back</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes sharply higher as Big Tech roars back\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-06 06:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Facebook bounces as services resume following outage</li>\n <li>Tech and financials among top advancers</li>\n <li>PepsiCo gains on raising annual revenue forecast</li>\n <li>Indexes: Dow +0.92%, S&amp;P 500 +1.05%, Nasdaq +1.25%</li>\n</ul>\n<p>Oct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.</p>\n<p>Apple, Microsoft, Amazon&nbsp;and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.</p>\n<p>Facebook Inc&nbsp;rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with financials, communication services&nbsp;and technology&nbsp;leading the way.</p>\n<p>The S&amp;P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.</p>\n<p>\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"</p>\n<p>Technology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.</p>\n<p>The Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.</p>\n<p>Investors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.</p>\n<p>Adding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.</p>\n<p>Data from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.92% to end at 34,314.67 points, while the S&amp;P 500&nbsp;gained 1.05% to 4,345.72.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.25% to 14,433.83.</p>\n<p>The S&amp;P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.</p>\n<p>PepsiCo Inc&nbsp;gained 0.6% after raising its full-year revenue forecast.</p>\n<p>Volume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","AMZN":"亚马逊",".SPX":"S&P 500 Index","AAPL":"苹果","MSFT":"微软","GOOG":"谷歌","GOOGL":"谷歌A",".DJI":"道琼斯","PEP":"百事可乐"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101968131","content_text":"Facebook bounces as services resume following outage\nTech and financials among top advancers\nPepsiCo gains on raising annual revenue forecast\nIndexes: Dow +0.92%, S&P 500 +1.05%, Nasdaq +1.25%\n\nOct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.\nApple, Microsoft, Amazon and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.\nFacebook Inc rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.\nNine of the 11 major S&P 500 sector indexes rose, with financials, communication services and technology leading the way.\nThe S&P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.\n\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"\nTechnology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.\nThe Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.\nInvestors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.\nAdding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.\nData from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.\nThe Dow Jones Industrial Average rose 0.92% to end at 34,314.67 points, while the S&P 500 gained 1.05% to 4,345.72.\nThe Nasdaq Composite climbed 1.25% to 14,433.83.\nThe S&P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.\nPepsiCo Inc gained 0.6% after raising its full-year revenue forecast.\nVolume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.\nThe S&P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":329258414,"gmtCreate":1615253325338,"gmtModify":1703486274955,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[惊讶]&nbsp;","listText":"[惊讶]&nbsp;","text":"[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/329258414","repostId":"1166350867","repostType":4,"repost":{"id":"1166350867","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1615215209,"share":"https://www.laohu8.com/m/news/1166350867?lang=&edition=full","pubTime":"2021-03-08 22:53","market":"us","language":"en","title":"Apple stock sank more than 2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166350867","media":"老虎资讯综合","summary":"Apple stock sank more than 2% on Monday.Rumors that Apple Inc (NASDAQ: AAPL) will hold a special har","content":"<p>Apple stock sank more than 2%&nbsp;on&nbsp;Monday.Rumors that&nbsp;<b>Apple Inc</b> (NASDAQ: AAPL) will hold a special hardware event next month and release new iPad Pro models, iPad mini, and AirTags have been dismissed by a leading watcher of the tech giant, Apple Insider reported Sunday.</p><p><img src=\"https://static.tigerbbs.com/6b6f4d601a19418bfb008c7cc9bc7f52\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple stock sank more than 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple stock sank more than 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-08 22:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Apple stock sank more than 2%&nbsp;on&nbsp;Monday.Rumors that&nbsp;<b>Apple Inc</b> (NASDAQ: AAPL) will hold a special hardware event next month and release new iPad Pro models, iPad mini, and AirTags have been dismissed by a leading watcher of the tech giant, Apple Insider reported Sunday.</p><p><img src=\"https://static.tigerbbs.com/6b6f4d601a19418bfb008c7cc9bc7f52\" tg-width=\"840\" tg-height=\"470\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166350867","content_text":"Apple stock sank more than 2% on Monday.Rumors that Apple Inc (NASDAQ: AAPL) will hold a special hardware event next month and release new iPad Pro models, iPad mini, and AirTags have been dismissed by a leading watcher of the tech giant, Apple Insider reported Sunday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":609422619,"gmtCreate":1638319233970,"gmtModify":1638319234461,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/609422619","repostId":"2188758534","repostType":4,"repost":{"id":"2188758534","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638310020,"share":"https://www.laohu8.com/m/news/2188758534?lang=&edition=full","pubTime":"2021-12-01 06:07","market":"hk","language":"en","title":"Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2188758534","media":"Dow Jones","summary":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\n","content":"<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&amp;P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&amp;P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&amp;P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDow closes 650 points lower Tuesday as Powell helps to ignite fresh stock-market selloff\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-01 06:07</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant</p>\n<p>U.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.</p>\n<p>Equities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.</p>\n<p>How did stock indexes trade?</p>\n<p>The Dow and S&amp;P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.</p>\n<p>For the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&amp;P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.</p>\n<p>What drove the markets?</p>\n<p>Federal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.</p>\n<p>Powell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.</p>\n<p>Powell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.</p>\n<p>In One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&amp;P 500 levels in focus</p>\n<p>\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.</p>\n<p>\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.</p>\n<p>Powell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"</p>\n<p>Investors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.</p>\n<p>Stocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.</p>\n<p>\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna <a href=\"https://laohu8.com/S/MRNA\">$(MRNA)$</a> shares fell 4.4%.</p>\n<p>Bancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.</p>\n<p>\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.</p>\n<p>Analysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.</p>\n<p>Bancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"</p>\n<p>Echoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.</p>\n<p>\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"</p>\n<p>The Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.</p>\n<p>Earlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.</p>\n<p>\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯","MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188758534","content_text":"Equities suffer after Moderna CEO raises worries over vaccine effectiveness against omicron variant\nU.S. stocks fell Tuesday, with all three major indexes closing sharply lower, after Federal Reserve Chairman Jerome Powell told lawmakers it would be appropriate for policy makers to consider winding down monthly asset purchases more quickly than planned.\nEquities were already feeling pressure after Moderna Inc.'s chief executive officer predicted that current vaccines would be less effective against the new omicron variant of the coronavirus that causes COVID-19.\nHow did stock indexes trade?\nThe Dow and S&P 500 traded below their lows from Friday's initial omicron-inspired selloff, which saw the indexes post their biggest one-day drops of the year before bouncing modestly in Monday's session.\nFor the month of November, the Nasdaq Composite gained 0.3% while the Dow dropped 3.7% and the S&P 500 slipped 0.8%, according to FactSet data. The Russell 2000 index saw a 4.3% decline in November.\nWhat drove the markets?\nFederal Reserve Chairman Jerome Powell, testifying alongside Treasury Secretary Janet Yellen, told the Senate Banking Committee that it would be appropriate given the present economic backdrop to consider speeding up the tapering process, with a decision to come after reviewing the latest jobs and inflation data ahead of the central bank's mid-December policy meeting.\nPowell also backed away from the Fed's long-running characterization of inflationary pressures as \"transitory,\" or short-lived. \"It's probably a good time to retire that word and explain more clearly what we mean,\" he said.\nPowell seemed \"a little more cautious\" on inflation, said James Ragan, director of wealth management research at D.A. Davidson, in a phone interview Tuesday. His remarks about tapering and inflation come at a time people are worried about the emergence of the omicron variant of the coronavirus and whether it could lead to a slowdown in economic growth, said Ragan.\nIn One Chart:'Markets don't bottom on a Friday': Stock rout puts these S&P 500 levels in focus\n\"They're trying to thread the needle here as far as the best timing on\" tapering the central bank's monthly bond purchases, Ragan said. Inflation is still \"a risk to the market,\" he added, explaining that tapering faster perhaps allows the Fed to raise rates sooner to keep the rise in the cost of living under control as the economy continues its rebound in the pandemic.\n\"Reading between the lines, it appears that Chairman Powell has grown dramatically more concerned with the risk of sustained inflation, and is therefore looking to end the central bank's asset purchases sooner than initially outlined,\" said Matt Weller, global head of research at FOREX.com and City Index.\nPowell's comments \"have already sent a tempest through major markets,\" he said, in a note. \"U.S. indices, fearing the accelerated end of the easy money train, are testing their lowest levels of the month.\"\nInvestors had been eyeing Powell's testimony to gauge his take on omicron's economic impact amid concern that the variant could potentially slow activity as well as contribute to inflation through potential supply-chain troubles.\nStocks were already under pressure Tuesday following downbeat comments from vaccine maker Moderna's CEO, Stéphane Bancel, about the prospects for vaccines against the new omicron variant.\n\"There is no world, I think, where [the effectiveness] is the same level...we had with delta,\" Bancel told the Financial Times in an interview published early Tuesday. He said the scientists he's spoken to expect a \"material drop\" in effectiveness of current vaccines against omicron. Moderna $(MRNA)$ shares fell 4.4%.\nBancel cited the much higher number of mutations on the spike protein of the omicron variant and the speed at which it is currently spreading across Africa as reasons. He predicted vaccine manufacturers would need several months to mass produce a vaccine that would be effective against omicron.\n\"This is once again a COVID-driven market and any negative headlines about vaccine effectiveness or the severity of omicron infections could cause more risk-off money flows as the odds of new lockdowns in parts of the world would rise as a result,\" wrote Tom Essaye, founder of Sevens Report Research, in a note.\nAnalysts had warned on Monday that a relatively sanguine outlook about the variant among investors could leave markets prone to volatility in reaction to negative headlines.\nBancel's comments came a day after President Joe Biden said omicron was concerning, but no reason to panic, and the fight against it wouldn't involve \"shutdowns or lockdowns.\"\nEchoing Friday's selloff that followed the discovery of the omicron variant, West Texas Intermediate crude prices tumbled 5.4% Tuesday to settle at $66.18 a barrel while investors sought shelter in government bonds. The yield on the 10-year Treasury note , which moves in the opposite direction of price, fell about 9 basis points to 1.44%.\n\"We view the selloff on the omicron variant as an opportunity to buy\" stocks said Sam Solem, a portfolio manager with Intrepid Private Wealth, by phone Tuesday. \"I don't think we're going back to the strict measures that we had in spring of 2020.\"\nThe Conference Board said Tuesday that its index of consumer confidence dropped to 109.5 from 111.6 in October, the lowest reading in nine months.\nEarlier, a reading on Chicago-area manufacturing activity, the Chicago Business Barometer, also known as the Chicago PMI, was at 61.8 in November, compared with 68.4 in the prior month. Readings over 50 signal expansion.\n\"We have a healthy economy, but we're definitely slowing down,\" Solem said. \"The market could be challenged in the second half of 2022.\" The portfolio manager now prefers high-quality U.S. large-cap stocks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":829374520,"gmtCreate":1633477873122,"gmtModify":1633477874763,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/829374520","repostId":"1101968131","repostType":4,"repost":{"id":"1101968131","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1633473672,"share":"https://www.laohu8.com/m/news/1101968131?lang=&edition=full","pubTime":"2021-10-06 06:41","market":"us","language":"en","title":"Wall Street closes sharply higher as Big Tech roars back","url":"https://stock-news.laohu8.com/highlight/detail?id=1101968131","media":"Reuters","summary":"Oct 5  - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.Apple, Microsoft, Amazon and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.Facebook Inc rebounded 2.1% a day after taking a beating when its a","content":"<ul>\n <li>Facebook bounces as services resume following outage</li>\n <li>Tech and financials among top advancers</li>\n <li>PepsiCo gains on raising annual revenue forecast</li>\n <li>Indexes: Dow +0.92%, S&amp;P 500 +1.05%, Nasdaq +1.25%</li>\n</ul>\n<p>Oct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.</p>\n<p>Apple, Microsoft, Amazon&nbsp;and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.</p>\n<p>Facebook Inc&nbsp;rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with financials, communication services&nbsp;and technology&nbsp;leading the way.</p>\n<p>The S&amp;P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.</p>\n<p>\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"</p>\n<p>Technology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.</p>\n<p>The Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.</p>\n<p>Investors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.</p>\n<p>Adding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.</p>\n<p>Data from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.92% to end at 34,314.67 points, while the S&amp;P 500&nbsp;gained 1.05% to 4,345.72.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.25% to 14,433.83.</p>\n<p>The S&amp;P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.</p>\n<p>PepsiCo Inc&nbsp;gained 0.6% after raising its full-year revenue forecast.</p>\n<p>Volume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes sharply higher as Big Tech roars back</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes sharply higher as Big Tech roars back\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-06 06:41</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<ul>\n <li>Facebook bounces as services resume following outage</li>\n <li>Tech and financials among top advancers</li>\n <li>PepsiCo gains on raising annual revenue forecast</li>\n <li>Indexes: Dow +0.92%, S&amp;P 500 +1.05%, Nasdaq +1.25%</li>\n</ul>\n<p>Oct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.</p>\n<p>Apple, Microsoft, Amazon&nbsp;and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.</p>\n<p>Facebook Inc&nbsp;rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.</p>\n<p>Nine of the 11 major S&amp;P 500 sector indexes rose, with financials, communication services&nbsp;and technology&nbsp;leading the way.</p>\n<p>The S&amp;P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.</p>\n<p>\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"</p>\n<p>Technology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.</p>\n<p>The Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.</p>\n<p>Investors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.</p>\n<p>Adding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.</p>\n<p>Data from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.</p>\n<p>The Dow Jones Industrial Average&nbsp;rose 0.92% to end at 34,314.67 points, while the S&amp;P 500&nbsp;gained 1.05% to 4,345.72.</p>\n<p>The Nasdaq Composite&nbsp;climbed 1.25% to 14,433.83.</p>\n<p>The S&amp;P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.</p>\n<p>PepsiCo Inc&nbsp;gained 0.6% after raising its full-year revenue forecast.</p>\n<p>Volume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","AMZN":"亚马逊",".SPX":"S&P 500 Index","AAPL":"苹果","MSFT":"微软","GOOG":"谷歌","GOOGL":"谷歌A",".DJI":"道琼斯","PEP":"百事可乐"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101968131","content_text":"Facebook bounces as services resume following outage\nTech and financials among top advancers\nPepsiCo gains on raising annual revenue forecast\nIndexes: Dow +0.92%, S&P 500 +1.05%, Nasdaq +1.25%\n\nOct 5 (Reuters) - Wall Street ended sharply higher on Tuesday, as Microsoft and Apple spearheaded a strong rebound in growth stocks and investors awaited monthly payrolls data later this week that could influence the U.S. Federal Reserve's decision on when to scale back monetary stimulus.\nApple, Microsoft, Amazon and Alphabet, Wall Street's most valuable companies, each rose more than 1% following a selloff in growth stocks the day before.\nFacebook Inc rebounded 2.1% a day after taking a beating when its app and its photo-sharing platform Instagram went offline for hours.\nNine of the 11 major S&P 500 sector indexes rose, with financials, communication services and technology leading the way.\nThe S&P 500 logged its fourth straight day of 1% moves in either direction. The last time the index saw that much volatility was in November 2020, when it rose or fell 1% or more for seven straight sessions.\n\"We're buying the dip, but the dip isn't 10% anymore. The dip is now 2%, or 4%,\" said Jake Dollarhide, chief executive officer of Longbow Asset Management in Tulsa, Oklahoma. \"People are trained like Pavlov's dog to buy the dip, which is reinforcing all of this.\"\nTechnology stocks and other high-growth stocks took a beating on Monday as U.S. Treasury yields ticked higher amid concerns about a potential U.S. government debt default.\nThe Senate will vote on Wednesday on a Democratic-backed measure to suspend the U.S. debt ceiling, a key lawmaker said on Tuesday, as partisan brinkmanship in Congress risks an economically crippling federal credit default.\nInvestors will watch September employment data on Friday for hints about the tapering of the U.S. Federal Reserve's asset purchase program.\nAdding to concerns the Fed could tighten monetary policy sooner than expected, recent data showed increased consumer spending, accelerated factory activity and elevated inflation.\nData from the Institute for Supply Management showed its U.S. non-manufacturing activity index edged up to a reading of 61.9 last month from 61.7 in August.\nThe Dow Jones Industrial Average rose 0.92% to end at 34,314.67 points, while the S&P 500 gained 1.05% to 4,345.72.\nThe Nasdaq Composite climbed 1.25% to 14,433.83.\nThe S&P 500 is down more than 3% from its record high close on Sept. 2. However, about half of the index's components have fallen 10% or more from their own 52-week highs.\nPepsiCo Inc gained 0.6% after raising its full-year revenue forecast.\nVolume on U.S. exchanges was 10.3 billion shares, compared with the 10.9 billion average over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.45-to-1 ratio; on Nasdaq, a 1.43-to-1 ratio favored advancers.\nThe S&P 500 posted 16 new 52-week highs and 7 new lows; the Nasdaq Composite recorded 71 new highs and 207 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":730,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874216365,"gmtCreate":1637790855939,"gmtModify":1637790856394,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/874216365","repostId":"1147995035","repostType":4,"isVote":1,"tweetType":1,"viewCount":664,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879403155,"gmtCreate":1636759420177,"gmtModify":1636759420669,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/879403155","repostId":"879195458","repostType":1,"repost":{"id":879195458,"gmtCreate":1636687707970,"gmtModify":1636733442557,"author":{"id":"126199392658083","authorId":"126199392658083","name":"机构有话说","avatar":"https://static.tigerbbs.com/d8a79f8da6559cae9d644c1c24d24737","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"title":"美股的利空是被暂时压制，突然爆发的一天可能不远了","htmlText":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","listText":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","text":"来源：CMEGroup 在9月短暂的回调之后，美股在10月份重启涨势，并再创新高，且涨势持续到11月上旬。此前，我们担忧三大因素可能引发美股调整：美联储宣布削减QE带来实际利率反弹，美股三季报不及预期和美国高通胀。但实际情况是三季度降幅好于市场预期，由于经济前景不佳和美国财政部削减发债规模，美元名义利率在美联储宣布削减QE后并没有大幅攀升，利空暂时没有引爆。 然而，我们认为美股估值偏高，就连美联储发布半年度金融稳定报告也对美股涨势超过经济增长基本面而发出警告。因此对于美股而言，我们倾向于存在调整的风险因素，但是美股出现持续大幅度下跌可能性较小。从历史情况来看，除非美国爆发经济危机或金融危机，否则美股很容易因市场预期美联储不敢过度紧缩而重新回升。 触发美股调整的三个风险因素 从中短期来看，美股多空因素交织，但是触发调整的风险更大，具体因素包括以下几个方面： 一: 美联储宣布削减QE后意味着美联储货币政策进入紧缩周期。这也意味着全球货币宽松周期出现拐点，就算美股不会出现暴跌，但是也不容易继续扩大涨幅。回顾2013-2015年紧缩周期，美股在削减QE早期还存在惯性的冲高，但是中后期表现从高位震荡转为加息后的连续三个月下跌。 2013-2015年美联储削减QE路径：2013年12月美联储议息会议宣布2022年1月削减QE（每个月削减100亿MBS和50亿长期国债）——2014年11月结束QE——2015年12月17日开始美联储加息。 美股表现如下：2013年12月宣布2014年1月正式削减QE，2014年1月，美国标普500指数当月下跌了3.56%，跌幅较小，并在2015年2月前继续创新高，之后在2015年3月至12月加息前高位震荡。2015年12月宣布加息后，标普500指数连续下跌三个月。 二：美国财政支出法案规模不断缩水，2022年美国经济增长可能不够强劲。企业债务过高在美元名","images":[{"img":"https://static.tigerbbs.com/493bd241b2cc511739e806ebe4a1f4cb","width":"-1","height":"-1"}],"top":1,"highlighted":2,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879195458","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":596,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":329258414,"gmtCreate":1615253325338,"gmtModify":1703486274955,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"[惊讶]&nbsp;","listText":"[惊讶]&nbsp;","text":"[惊讶]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/329258414","repostId":"1166350867","repostType":4,"isVote":1,"tweetType":1,"viewCount":379,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698784280,"gmtCreate":1640559121390,"gmtModify":1640559122516,"author":{"id":"3561674412609852","authorId":"3561674412609852","name":"HengKuan","avatar":"https://static.tigerbbs.com/62bcac9aecdc128035098328c87aa231","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698784280","repostId":"1144001147","repostType":4,"repost":{"id":"1144001147","pubTimestamp":1640485026,"share":"https://www.laohu8.com/m/news/1144001147?lang=&edition=full","pubTime":"2021-12-26 10:17","market":"us","language":"en","title":"A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State","url":"https://stock-news.laohu8.com/highlight/detail?id=1144001147","media":"InvestorPlace","summary":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, t","content":"<p>In the last year,&nbsp;<b>Ocugen</b>(NASDAQ:<b><u>OCGN</u></b>) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.</p>\n<p>However, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with&nbsp;<b>Bharat Biotech</b>. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.</p>\n<p>Beyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.</p>\n<p>Ocugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.</p>\n<p>Let’s talk about the reasons to be bearish.</p>\n<p>FDA Approval Remains Elusive</p>\n<p><b>Pfizer</b>(NYSE:<b><u>PFE</u></b>) and&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.</p>\n<p>Back in June, the biotech company’s&nbsp;application for emergency use authorization&nbsp;was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.</p>\n<p>In November, Ocugen announced that the FDA has “issued a clinical hold&nbsp;on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.</p>\n<p>The key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.</p>\n<p>In July, Ocugen had also initiated a&nbsp;rolling submission to Health Canada&nbsp;for the vaccine. There is no positive news on that front either.</p>\n<p>Let’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.</p>\n<p>Can Omicron Provide a Lifeline for OCGN Stock?</p>\n<p>The omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are&nbsp;currently studying the effectiveness&nbsp;of the vaccine against the variant.</p>\n<p>If the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.</p>\n<p>First and foremost, Moderna has announced that its Covid-19 booster&nbsp;increases neutralizing antibodies 37-fold&nbsp;against Omicron variant.</p>\n<p>Furthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold&nbsp;compared to two doses against the Omicron variant.”</p>\n<p>Clearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.</p>\n<p>People who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.</p>\n<p>It’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.</p>\n<p>OCGN Stock Will Trend Lower</p>\n<p>OCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.</p>\n<p>The company is&nbsp;building a pipeline of drugs&nbsp;for various indications. However, the pipeline for various indications is still at a pre-clinical stage.</p>\n<p>The stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.</p>\n<p>It also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Year After Announcing a Big Partnership, Ocugen Is in a Sorry State</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Year After Announcing a Big Partnership, Ocugen Is in a Sorry State\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there...</p>\n\n<a href=\"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://investorplace.com/2021/12/a-year-after-its-big-partnership-with-bharat-ocgn-stock-is-in-a-sorry-state/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144001147","content_text":"In the last year, Ocugen(NASDAQ:OCGN) stock is still among the top performers. During this period, the stock has surged by over 500%. The stock’s ascent began after Dec. 21, 2020 — starting from there, the stock is up over 1,600%.\nHowever, it’s worth noting that OCGN stock was trading well below one dollar before it stitched a partnership with Bharat Biotech. The companies announced plans to begin manufacturing Covid-19 vaccines in the U.S. on Dec. 22 last year.\nBeyond the news of this partnership, there has been little to cheer for investors. OCGN stock traded at all-time highs of $18.77 in February and reached slightly lower peaks in May and November. The stock traded at $5.12 at the start of Dec. 23.\nOcugen will continue to underperform going forward. Even after the downtrend in the last few months, OCGN stock should be avoided.\nLet’s talk about the reasons to be bearish.\nFDA Approval Remains Elusive\nPfizer(NYSE:PFE) and Moderna(NASDAQ:MRNA) have been leaders in the vaccine race in the U.S. In a country where more than 70% of the population has already been vaccinated, Ocugen has yet to secure an approval from the U.S. Food and Drug Administration.\nBack in June, the biotech company’s application for emergency use authorization was rejected by the FDA. The recommendation by the FDA was to file for a biologics license application, which implies full approval.\nIn November, Ocugen announced that the FDA has “issued a clinical hold on the Company’s Investigational New Drug application (IND) to evaluate the COVID-19 vaccine candidate.” The FDA will be identifying the specific deficiencies that form a basis for the clinical hold. Once Ocugen addresses these deficiencies, there will be some progress.\nThe key point is that it’s been over a year since Ocugen announced the partnership with Bharat Biotech. The company has still been unsuccessful from an approval perspective.\nIn July, Ocugen had also initiated a rolling submission to Health Canada for the vaccine. There is no positive news on that front either.\nLet’s imagine a scenario where Ocugen receives an approval for vaccine use in Q1 2022. This is very unlikely. However, even in an optimistic case scenario, Ocugen needs to compete in a market where vaccination percentage is high. There is unlikely to be a case for strong revenue and cash flow growth.\nCan Omicron Provide a Lifeline for OCGN Stock?\nThe omicron variant has been a cause of concern for governments globally. Ocugen and partner Bharat Biotech are currently studying the effectiveness of the vaccine against the variant.\nIf the vaccine proves to be effective, can it be a game-changer for Ocugen? Most likely, no.\nFirst and foremost, Moderna has announced that its Covid-19 booster increases neutralizing antibodies 37-fold against Omicron variant.\nFurthermore, Pfizer has announced that a third dose increases the “neutralizing antibody by 25-fold compared to two doses against the Omicron variant.”\nClearly, the leading vaccine makers have an edge. Even if Ocugen announces that its vaccine is effective against the omicron variant, the stock is unlikely to trend higher.\nPeople who have already taken two shots of Moderna or Pfizer are unlikely to pursue a booster shot with Ocugen. Additionally, Ocugen is still struggling for approval.\nIt’s also worth noting that Ocugen needs to share revenue with Bharat Biotech. The visibility for healthy cash flows is therefore very unlikely.\nOCGN Stock Will Trend Lower\nOCGN stock is likely to continue trending lower in the coming months. Without an approval, the company is rapidly losing out on any revenue and cash flow potential.\nThe company is building a pipeline of drugs for various indications. However, the pipeline for various indications is still at a pre-clinical stage.\nThe stock trend will therefore be dictated by the outcome of Covid-19 vaccine approval and revenue potential. Things seem bleak on that front.\nIt also seems unlikely that Ocugen has a capability to expand the vaccine partnership with Bharat Biotech to other countries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":449,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}